ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00436787
Recruitment Status : Completed
First Posted : February 19, 2007
Last Update Posted : May 16, 2008
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : December 2007